8-KEarnings & ResultsRegulation FDOther Events+1

METLIFE INC 8-K Report, Financial Results (Jan 31, 2024)

Filed January 31, 2024For Securities:METMET-PEMET-PFMET-PA

Summary

MetLife, Inc. (MET) filed an 8-K on January 31, 2024, primarily to furnish its fourth quarter and full-year 2023 earnings release, quarterly financial supplement, and a total assets under management (AUM) fact sheet. The filing also includes supplemental slides with outlook information. Investors should note that the company's outlook for 2024 acknowledges continued economic uncertainty, particularly regarding inflation and unemployment, but expresses confidence in its diversified investment portfolio and strong liquidity position. The company has $5.2 billion in holding company cash, exceeding its target range of $3.0 billion to $4.0 billion. MetLife anticipates maintaining this cash level in 2024 and expects to avoid material liquidity deficiencies. The outlook is based on specific assumptions for interest rates, equity returns, and private equity performance, projecting a free cash flow to adjusted earnings ratio of 65% to 75% and an adjusted return on equity of 13% to 15%. Furthermore, MetLife is lowering its full-year direct expense ratio target, reflecting a commitment to efficiency and reinvestment in growth.

Key Highlights

  • 1MetLife released its Q4 and full-year 2023 financial results and provided an outlook for 2024.
  • 2The company holds $5.2 billion in holding company cash, exceeding its target range of $3.0 billion to $4.0 billion.
  • 3MetLife expects to maintain its holding company cash target in 2024 and does not anticipate material liquidity deficiencies.
  • 4Outlook for 2024 incorporates continued economic uncertainty (inflation, unemployment) but expects a stable US dollar and yield curve steepening.
  • 5Projected free cash flow to adjusted earnings ratio of 65%-75% for 2024, assuming specific interest rate and equity market performance.
  • 6Targeting an adjusted return on equity (excluding certain items) of 13%-15% in the near-term.
  • 7Lowering full-year direct expense ratio target to 12.3% from 12.6%, demonstrating a focus on efficiency.

Frequently Asked Questions